Results 251 to 260 of about 855,325 (373)
Complications after Oncoplastic Breast Reduction and Impact on Time to Adjuvant Therapy. [PDF]
Moen M+7 more
europepmc +1 more source
Abstract Purpose This work introduces BreastWatch, a Varian Eclipse script tool designed to help medical physicists, dosimetrists, and radiation oncologists easily inspect and improve External Beam Breast Treatment (EBBT) plans using automatic evaluation of protocol dose‐constraints enhanced by a Community‐Based approach.
Stefano Agostinelli+8 more
wiley +1 more source
Comparative Outcomes of Superomedial and Inferior Pedicles in Breast Reduction and Mastopexy: A Meta-Analysis of 5123 Breasts. [PDF]
Tanas Y, Tanas J.
europepmc +1 more source
Return to Work after Breast Reduction: A Comparative Study. [PDF]
Holopainen N+4 more
europepmc +1 more source
Predicting Breast Reduction Weight Using the Mass of Breast Ptosis [PDF]
John Murray+3 more
openalex +1 more source
Abstract Purpose Breast cancer is a neoplastic disease with high prevalence among women. Radiotherapy is one of the principal treatment modalities for this disease, but it poses significant challenges. This study aimed to compare and evaluate the technical and dosimetric performance of conventional C‐arm linac systems and a new design, Halcyon, in the ...
Mustafa Çağlar+8 more
wiley +1 more source
Efficacy of pectoralis nerve blocks I & II with liposomal bupivacaine in patients undergoing elective breast reduction procedures: A retrospective study. [PDF]
Sanghvi AP+4 more
europepmc +1 more source
Abstract Purpose Volumetric‐modulated arc therapy (VMAT) treatment planning allows a compromise between a sufficient coverage of the planning target volume (PTV) and a simultaneous sparing of organs‐at‐risk (OARs). Particularly in the case of lung tumors, deciding whether it is possible or worth spending more time on further improvements of a treatment
Johann Brand+4 more
wiley +1 more source
Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast [PDF]
Lars Holmberg+8 more
openalex +1 more source
Abstract Objectives Intravenous immunoglobulin (IVIg) is an effective treatment for Guillain–Barré syndrome (GBS), but recovery varies between patients. This study aims to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of a single and a second IVIg dose (SID) in patients with GBS.
Sander J. van Tilburg+7 more
wiley +1 more source